Digital Therapeutics Market size, Growth, Forecast 2021 JULY 2018

Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021 The Market Research on Digital Therapeutics, By Considering useful aspects like; Application, End Users- Global Future Forecast till 2021, published by MarketsandMarkets™, the report studies the global Digital Therapeutics market over the forecast period of 2017 to 2021. The market is projected to reach USD 457.9 Million by 2021 at a CAGR of 27.7%. The study estimates the Digital Therapeutics market size for 2018 and projects its demand till 2021. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include research scientists, Digital Therapeutics specialists, laboratory technicians, and R&D professionals of pharmaceutical and biotechnology companies and academic research institutes. For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the Digital Therapeutics market as well as to estimate the market size of various other dependent submarkets. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. North America dominates the digital therapeutics market, with the U.S. accounting for the major share and highest CAGR. This can be attributed to the growing incidence of chronic diseases, government initiatives to support technological advancements in digital therapeutics, gradually improving reimbursement structure for digital therapeutics solutions, and a growing influx of new startup companies in the market as a result of increasing investments in the digital therapeutics field. For instance, in July 2014, Proteus Digital Health (U.S.) secured an investment of USD 172 million from a list of institutional investors for the manufacturing and development of its digital medicine products. The Digital Therapeutics market is fragmented with the presence of emerging players; 1